Skip to main content
editor@jprims.in
9343055451
e-ISSN: 3049-1681
Journal of Pharmaceutical Research and Integrated Medical Sciences

Journal of Pharmaceutical Research and Integrated Medical Sciences

Published

Multimodal AI and Machine Learning for Predictive Risk Stratification, Early Detection, And Clinical Management of Pica: Integrating Etiological and Pathophysiological Biomarkers

Published in JPRIMS, Vol-3, Issue-09, September-2026 (Vol. 3, Issue 9, 2026)

Multimodal AI and Machine Learning for Predictive Risk Stratification, Early Detection, And Clinical Management of Pica: Integrating Etiological and Pathophysiological Biomarkers - Issue cover

Abstract

Pica is a clinically significant and often overlooked feeding and eating disorder in which individuals have a persistent urge to eat or chew non-nutritious or non-food items and is linked to nutritional, hematological, behavioral, and environmental issues. Human studies have regularly found links between pica and iron deficiency and anemia, as well as between changes in hematological parameters, decreased ferritin, and decreased zinc concentrations; toxic-element exposure may also be a part of certain behaviors (like geophagia). The review critically summarises the potential use of multimodal artificial intelligence (AI) and machine learning (ML) to support predictive risk stratification, early detection, and clinical management of pica, highlighting the importance of combining etiological and pathophysiological biomarkers, clinical, behavioural, toxicological and electronic health-record data. Biomarker evidence also indicates human exposure to multiple biomarkers together may be a more complete risk profile than single biomarkers, since there are human data from which to draw conclusions. AI and natural language processing could be used to identify undetected pica-related behaviors and track changes over time to clinical and laboratory data. However, there are still limitations in the development and validation of pica-specific AI models, and existing evidence from related conditions mainly methodologically supports the use of AI. Further studies are needed on large, prospective, diverse human cohorts, standardized pica phenotyping, longitudinal assessment of biomarkers, explainable AI, external validation, and prospective clinical assessment. Finally, multimodal AI should be used as a clinically interpretable decision support system, not as an independent diagnostic system.

Authors (8)

Yash Srivastav

D.K.R.R Pharmacy College, Ambe...

View all publications →

Stuti Verma

Aryakul College of Pharmacy an...

View all publications →

Kamini Prajapati

D.K.R.R Pharmacy College, Ambe...

View all publications →

Sandeep Prakash

D.K.R.R Pharmacy College, Ambe...

View all publications →

Rajeev Kumar

Aryakul College of Pharmacy an...

View all publications →

Anubha Dhuriya

Aryakul College of Pharmacy an...

View all publications →

Anup Kumar Sirbaiya

K.P. Singh Memorial Institute ...

View all publications →

Shivani Singh

D.K.R.R Pharmacy College, Ambe...

View all publications →

Download Article

PDF

Best for printing and citation

File size: 1.2 MB
Format: PDF

Summarise this paper with AI:

Article Information

JPRIMS930001

JPRIMS-01-000297

1-19

2026-09-03

JATS XML

Article Impact

Views:5,403
Downloads:2,414
scite_
PlumX Metrics Badge

How to Cite

Srivastav, Y., Verma, S., Prajapati, K., Prakash, S., Kumar, R., Dhuriya, A., Kumar Sirbaiya, A., & Singh, S. (2026). Multimodal AI and Machine Learning for Predictive Risk Stratification, Early Detection, And Clinical Management of Pica: Integrating Etiological and Pathophysiological Biomarkers. Journal of Pharmaceutical Research and Integrated Medical Sciences, 3(9), 1-19. https://doi.org/10.64063/3049-1681.vol3.issue9.000297

Article Actions